Walgreens Boots Alliance Inc. (NASDAQ: WBA) is set to go private after nearly a century as a publicly traded company. Private equity firm Sycamore Partners has agreed to acquire Walgreens in a leveraged buyout worth up to $23.7 billion, including debt and potential future payouts.
Under the deal, Sycamore will pay $11.45 per share in cash, with Walgreens shareholders eligible for up to an additional $3 per share based on the sale of the company’s primary-care assets. Factoring in assumed debt, the transaction could reach a total valuation of $24 billion.
Walgreens CEO Tim Wentworth emphasized that while the company has made progress on its turnaround strategy, transitioning to a private entity will allow for more efficient restructuring. He highlighted Sycamore’s expertise in retail turnarounds as a key advantage for the company’s future growth.
The acquisition follows Walgreens' struggles in the competitive pharmacy and retail healthcare industry. By going private, Walgreens aims to streamline operations and navigate market challenges without the pressures of public trading.
The deal includes a 35-day “go-shop” period, allowing Walgreens to seek alternative offers. Pending regulatory approvals, the acquisition is expected to close in the fourth quarter of this year. Investors will closely monitor the transaction, marking one of the largest leveraged buyouts in recent years.


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Instagram Outage Disrupts Thousands of U.S. Users
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



